Patents by Inventor Hasmukh Ambalal Patel

Hasmukh Ambalal Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10729156
    Abstract: Exosome purification methods involve use of a whey composition as an exosome source. Exosomes are isolated by subjecting the whey composition to a first ultrafiltration, which yields a first permeate and a first retentate. The first retentate may then be subjected to a second ultrafiltration, yielding a second permeate and a second retentate. During the second ultrafiltration, the first retentate may be treated with carbon dioxide. The second retentate may then be subjected to a third ultrafiltration, yielding a third permeate and a third retentate. The third permeate may then be optionally dried to yield an exosome powder.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: August 4, 2020
    Assignee: PURINA ANIMAL NUTRITION LLC
    Inventors: Hasmukh Ambalal Patel, Samantha Steelman, Ravin Gnanasambandam, Benjamin R. Trible, Nathan Christopher Burke
  • Publication number: 20190150474
    Abstract: Exosome purification methods involve use of a whey composition as an exosome source. Exosomes are isolated by subjecting the whey composition to a first ultrafiltration, which yields a first permeate and a first retentate. The first retentate may then be subjected to a second ultrafiltration, yielding a second permeate and a second retentate. During the second ultrafiltration, the first retentate may be treated with carbon dioxide. The second retentate may then be subjected to a third ultrafiltration, yielding a third permeate and a third retentate. The third permeate may then be optionally dried to yield an exosome powder.
    Type: Application
    Filed: November 21, 2018
    Publication date: May 23, 2019
    Inventors: Hasmukh Ambalal Patel, Samantha Steelman, Ravin Gnanasambandam, Benjamin R. Trible, Nathan Christopher Burke
  • Publication number: 20190105371
    Abstract: Casein compositions for increasing the rate of gastric emptying following ingestion of the composition, increasing the digestibility of a protein composition, or increasing the rate of delivery of amino acids to the blood, or for increasing the blood serum concentration of free leucine in a subject, preferably to substantially the same level as whey protein, the casein being about 10 to about 100% calcium depleted, having a degree of hydrolysis less than about 1% and having an unmodified phosphorylation pattern.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 11, 2019
    Inventors: Aaron Calvin Fanning, Hasmukh Ambalal Patel, Johannes Schalk, Ramon Stafford Hall, Roger Richard Schwarzenbach, Sergey Yevgenievich Ukraintsev
  • Publication number: 20170232063
    Abstract: Casein compositions for increasing the rate of gastric emptying following ingestion of the composition, increasing the digestibility of a protein composition, or increasing the rate of delivery of amino acids to the blood, or for increasing the blood serum concentration of free leucine in a subject, preferably to substantially the same level as whey protein, the casein being about 10 to about 100% calcium depleted, having a degree of hydrolysis less than about 1% and having an unmodified phosphorylation pattern.
    Type: Application
    Filed: January 31, 2017
    Publication date: August 17, 2017
    Inventors: Aaron Calvin Fanning, Hasmukh Ambalal Patel, Johannes Schalk, Ramon Stafford Hall, Roger Richard Schwarzenbach, Sergey Yevgenievich Ukraintsev
  • Publication number: 20160235082
    Abstract: Different versions of heat stable whey protein ingredients can be produced by subjecting whey protein solutions to specific heat treatments in the presence of a specific concentration of hydrogen peroxide. The whey protein ingredients including heat stable liquid retentate of WPI, WPC or any other form of whey protein ingredients, and heat stable powders of WPI or WPC or any other whey protein powders can be prepared by heat treatment of a whey protein solution mixed with a hydrogen peroxide solution. The heat stable whey proteins have the starting whey protein cystine converted to cystine sulfonic acid, such that the free sulfhydral groups of major whey protein (?-lactoglobulin) being converted into non-reactive compounds, such as cysteine sulphonic acid and/or cysteic acid, which not only minimizes or eliminates undesirable gelling but also is a precursor for taurine group of compounds.
    Type: Application
    Filed: February 17, 2016
    Publication date: August 18, 2016
    Inventors: Hasmukh Ambalal PATEL, Suresh Ganpatbhai SUTARIYA
  • Publication number: 20150011468
    Abstract: Casein compositions for increasing the rate of gastric emptying following ingestion of the composition, increasing the digestibility of a protein composition, or increasing the rate of delivery of amino acids to the blood, or for increasing the blood serum concentration of free leucine in a subject, preferably to substantially the same level as whey protein, the casein being about 10 to about 100% calcium depleted, having a degree of hydrolysis less than about 1% and having an unmodified phosphorylation pattern.
    Type: Application
    Filed: March 11, 2013
    Publication date: January 8, 2015
    Applicant: FONTERRA CO-OPERATIVE GROUP LIMITED
    Inventors: Aaron Calvin FANNING, Hasmukh Ambalal PATEL, Johannes SCHALK, Ramon Stafford HALL, Roger Richard SCHWARZENBACH, Sergey Yevgenievich UKRAINTSEV
  • Patent number: 8062687
    Abstract: The present invention relates to a method of pressure treating a bioactive composition comprising at least one bioactive component to prevent the growth of at least one unwanted microorganism while retaining a desired level activity of the at least one bioactive component. The bioactive component is selected from one or more proteins protein hydrolysates, one or more lipids or lipid hydrolysates, one or more carbohydrates, one or more probiotic factors, or mixtures thereof. The pressure treatment is at a predetermined pressure from about 350 to 1000 MPa.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: November 22, 2011
    Assignee: Fonterra Co-Operative Group Limited
    Inventors: Timothy Joseph Carroll, Hasmukh Ambalal Patel, Miguel Alejandro Gonzalez-Martin, James William Dekker, Michael Anthony Collett, Marc William Lubbers
  • Publication number: 20080317823
    Abstract: The present invention relates to a method of pressure treating a bioactive composition comprising at least one bioactive component to prevent the growth of at least one unwanted microorganism while retaining a desired level activity of the at least one bioactive component. The bioactive component is selected from one or more proteins protein hydrolysates, one or more lipids or lipid hydrolysates, one or more carbohydrates, one or more probiotic factors, or mixtures thereof. The pressure treatment is at a predetermined pressure from about 350 to 1000 MPa.
    Type: Application
    Filed: March 8, 2006
    Publication date: December 25, 2008
    Inventors: Timothy Joseph Carroll, Hasmukh Ambalal Patel, Miguel Alejandro Gonzalez-Martin, James William Dekker, Michael Anthony Collett, Marc William Lubbers
  • Publication number: 20080166466
    Abstract: The present invention relates to a method of treating a composition comprising metal ion lactoferrin and in particular to a method of pressure treating a composition comprising metal ion lactoferrin to prevent the growth of at least one unwanted microorganism while retaining a desired level of metal ion binding.
    Type: Application
    Filed: March 8, 2006
    Publication date: July 10, 2008
    Applicant: Fonterra-Co-operative Group Limited
    Inventors: Kay Patricia Palmano, Timothy Joseph Carroll, Hasmukh Ambalal Patel, Miguel Alejandro Gonzalez-Martin, David Francis Elgar